Emerald Advisers, LLC Zoetis Inc. Transaction History

Emerald Advisers, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 31, 2018	SELL	$79.9 - $89.2 $753,057 - $840,710	-9,425 Closed	0 $0
Q1 2018 Apr 26, 2018	SELL	$71.51 - $84.69 $65,431 - $77,491	-915 Reduced 8.85%	9,425 $787,000
Q4 2017 Feb 05, 2018	SELL	$63.24 - $72.8 $33,833 - $38,948	-535 Reduced 4.92%	10,340 $745,000
Q3 2017 Oct 30, 2017	BUY	$59.73 - $65.4 $649,563 - $711,225	10,875	10,875 $693,000

1,858

416M

1.13M

1.81M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $81.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.